Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Moodys
McKesson
Boehringer Ingelheim
McKinsey

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nomegestrol acetate

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Nomegestrol acetate: Patents, clinical trial progress, indications

Nomegestrol acetate is an investigational drug.

There have been 15 clinical trials for Nomegestrol acetate. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Recurrence, Thrombophilia, and Multiple Sclerosis. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Mahidol University, and Grünenthal GmbH.

There are one hundred and fifty-five US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Nomegestrol acetate
TitleSponsorPhase
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateGrünenthal S.A.Phase 1
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateGrünenthal GmbHPhase 1
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal ContraceptionMahidol UniversityPhase 4

See all Nomegestrol acetate clinical trials

Clinical Trial Summary for Nomegestrol acetate

Top disease conditions for Nomegestrol acetate
Top clinical trial sponsors for Nomegestrol acetate

See all Nomegestrol acetate clinical trials

US Patents for Nomegestrol acetate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nomegestrol acetate   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Nomegestrol acetate   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Nomegestrol acetate   Start Trial Neuroprotection and myelin repair using Nestorone.RTM. The Population Council, Inc. (New York, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Nomegestrol acetate

Drugname Country Document Number Estimated Expiration Related US Patent
Nomegestrol acetate Canada 2961033 2034-09-11   Start Trial
Nomegestrol acetate European Patent Office 3192791 2034-09-11   Start Trial
Nomegestrol acetate Japan WO2016039408 2034-09-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Medtronic
Harvard Business School
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.